CVE-2026-66340: Mira Hormone Monitor, Mira Android App Improper restriction of excessive authentication attempts
Quanovate Tech Inc. (operating as Mira / Mira Care) · Mira Firmware
Vendor fix available · Affected: Quanovate Tech Inc. (operating as Mira / Mira Care) Mira Firmware · Exploitation: unlikely (under 1%)
Not in CyberSIXT coverage yet: no article names this CVE. This page shows the public record.
Higher than 34% of scored CVEs
DescriptionCVE.org
The Mira cloud authentication endpoints do not enforce per-account rate limiting, per-IP throttling, or account lockout after repeated failed login attempts. An attacker can use brute-force methods to obtain gain access to user accounts.
Affected products2
From the CVE record. A product or version that is not listed is unknown, not unaffected.
- Quanovate Tech Inc. (operating as Mira / Mira Care) · Mira Firmware1.7.1.47
- Quanovate Tech Inc. (operating as Mira / Mira Care) · Mira Android App4.5.15.4
On the Atlas
Every published CVE is on the CyberSIXT Atlas, grouped by weakness, vendor and month.
- Exploitation
- Unlikely (under 1%). EPSS under 1%, or no score yet.
- CISA KEV
- Not listed
- Public check
- No public nuclei template
- Published
- August 2026
CoverageNo articles yet
No CyberSIXT article names CVE-2026-66340 yet, so there is no coverage timeline, action brief or change log for it. Everything on this page comes from the public CVE record, CISA KEV, EPSS and the nuclei template index. Search the archive or see the CVEs in the news.